Crowdonomics
WatchlistPortfolio
This isn’t BioClonetics’s most recent raise. Reg CF · Convertible Note · Jan 2018 (Closed) is more current.View latest round
BioClonetics

Reg CF · SAFE · Apr 2017

ClosedReached targetReg CFSAFE
via WeFunder · last checked Aug 17, 2026
Raised
$255.6K / $1M max
26% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2015–FY2016 · hover for source
$0
−$41K
FY2015
$0
−$81K
FY2016
RevenueNet income
Metric
FY2015 reviewed
FY2016 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$40,774
-$80,591
Taxes paid
$0
$0
Balance sheet
Cash
$226
$1,195
Accounts receivable
$0
$0
Total assets
$226
$1,195
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Sep 1, 2017
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$200,000
Max$1,000,000
Min investment—
OpenedApr 11, 2017
DeadlineOct 8, 2017
ClosedOct 8, 2017
Days active180

Links & provenance

SEC filing
Source: SEC EDGAR
0001670254-17-000054
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.